BioMarin Unveils Groundbreaking Data on Achondroplasia Treatment at ASBMR Annual Meeting #USA #San_Rafael #BioMarin #VOXZOGO #achondroplasia
@newsen.bsky.social
@newsen.bsky.socialBioMarin Unveils Groundbreaking Data on Achondroplasia Treatment at ASBMR Annual Meeting #USA #San_Rafael #BioMarin #VOXZOGO #achondroplasia
@newsen.bsky.socialBioMarin Welcomes Cara Bauer as New Chief People Officer #USA #San_Rafael #BioMarin #Chief_People_Officer #Cara_Bauer
@newsen.bsky.socialBioMarin Unveils Five-Year Data on POMBILITI and OPFOLDA at World Muscle Society Congress #United_States #San_Rafael #BioMarin #POMBILITI #OPFOLDA
@newsen.bsky.socialBioMarin Welcomes Robert Plenge, M.D., Ph.D., to Its Board of Directors as New Chief Research Officer #United_States #San_Rafael #Rare_Diseases #BioMarin #Dr._Plenge
@newsen.bsky.socialBioMarin Presents Encouraging Phase 3 Results for VOXZOGO in Children with Hypochondroplasia #USA #San_Rafael #BioMarin #VOXZOGO #Hypochondroplasia